Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study

被引:147
|
作者
Ye, Zheng [1 ]
Sharp, Stephen J. [1 ]
Burgess, Stephen [2 ]
Scott, Robert A. [1 ]
Imamura, Fumiaki [1 ]
Langenberg, Claudia [1 ]
Wareham, Nicholas J. [1 ]
Forouhi, Nita G. [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,Epidemiol Unit, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
来源
LANCET DIABETES & ENDOCRINOLOGY | 2015年 / 3卷 / 01期
基金
英国惠康基金; 英国医学研究理事会;
关键词
VITAMIN-D STATUS; GENETIC-DETERMINANTS; INSULIN-RESISTANCE; D SUPPLEMENTATION; CONTROLLED-TRIAL; FASTING GLUCOSE; RISK; COHORT;
D O I
10.1016/S2213-8587(14)70184-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D concentration and risk of type 2 diabetes using a mendelian randomisation approach. Methods Using several data sources from populations of European descent, including type 2 diabetes cases and non-cases, we did a mendelian randomisation analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH) D synthesis and metabolism: DHCR7 (related to vitamin D synthesis), CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism). We assessed each SNP for an association with circulating 25(OH) D concentration (5449 non-cases; two studies), risk of type 2 diabetes (28 144 cases, 76 344 non-cases; five studies), and glycaemic traits (concentrations of fasting glucose, 2-h glucose, fasting insulin, and HbA(1c); 46 368 non-cases; study consortium). We combined these associations in a likelihood-based mendelian randomisation analysis to estimate the causal association of 25(OH) D concentration with type 2 diabetes and the glycaemic traits, and compared them with that from a meta-analysis of data from observational studies (8492 cases, 89 698 non-cases; 22 studies) that assessed the association between 25(OH) D concentration and type 2 diabetes. Findings All four SNPs were associated with 25(OH) D concentrations (p<10(-6)). The mendelian randomisation-derived unconfounded odds ratio for type 2 diabetes was 1.01 (95% CI 0.75-1.36; p = 0.94) per 25.0 nmol/L (1 SD) lower 25(OH) D concentration. The corresponding (potentially confounded) relative risk from the meta-analysis of data from observational studies was 1.21 (1.16-1.27; p = 7.3 x 10(-19)). The mendelian randomisation-derived estimates for glycaemic traits were not significant (p > 0.25). Interpretation The association between 25(OH)D concentration and type 2 diabetes is unlikely to be causal. Efforts to increase 25(OH)D concentrations might not reduce the risk of type 2 diabetes as would be expected on the basis of observational evidence. These findings warrant further investigations to identify causal factors that might increase 25(OH D concentration and also reduce the risk of type 2 diabetes. Copyright (C) Ye et al. Open Access article distributed under the terms of CC BY.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [31] Association between pre-diagnostic circulating 25-hydroxyvitamin D and cancer survival
    Weinstein, Stephanie J.
    Mondul, Alison
    Albanes, Demetrius
    CANCER RESEARCH, 2016, 76
  • [32] Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation
    Xiaomeng Zhang
    Yazhou He
    Xue Li
    Rasha Shraim
    Wei Xu
    Lijuan Wang
    Susan M. Farrington
    Harry Campbell
    Maria Timofeeva
    Lina Zgaga
    Peter Vaughan-Shaw
    Evropi Theodoratou
    Malcolm G. Dunlop
    British Journal of Cancer, 2024, 130 : 1585 - 1591
  • [33] Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation
    Zhang, Xiaomeng
    He, Yazhou
    Li, Xue
    Shraim, Rasha
    Xu, Wei
    Wang, Lijuan
    Farrington, Susan M.
    Campbell, Harry
    Timofeeva, Maria
    Zgaga, Lina
    Vaughan-Shaw, Peter
    Theodoratou, Evropi
    Dunlop, Malcolm G.
    BRITISH JOURNAL OF CANCER, 2024, 130 (09) : 1585 - 1591
  • [34] Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study
    Napoli, Nicola
    Schafer, Anne L.
    Lui, Li-Yung
    Cauley, Jane A.
    Strotmeyer, Elsa S.
    Le Blanc, Erin S.
    Hoffman, Andrew R.
    Lee, Christine G.
    Black, Dennis M.
    Schwartz, Ann V.
    BONE, 2016, 90 : 181 - 184
  • [35] No association between 25-hydroxyvitamin D and mammographic density
    Knight, Julia A.
    Vachon, Celine M.
    Vierkant, Robert A.
    Vieth, Reinhold
    Cerhan, James R.
    Sellers, Thomas A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1988 - 1992
  • [36] No evidence of a causal relationship between miscarriage and 25-hydroxyvitamin D: a Mendelian randomization study
    Zhang, Feng
    Huang, Jingtao
    Zhang, Gangting
    Dai, Mengyang
    Yin, Tailang
    Huang, Chunyu
    Liu, Jue
    Zhang, Yan
    HUMAN REPRODUCTION OPEN, 2024, 2024 (02)
  • [37] Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study
    Sun, Yi-Qian
    Brumpton, Ben M.
    Bonilla, Carolina
    Lewis, Sarah J.
    Burgess, Stephen
    Skorpen, Frank
    Chen, Yue
    Nilsen, Tom I. L.
    Romundstad, Pal Richard
    Mai, Xiao-Mei
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (06)
  • [38] Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection
    Thompson, George R.
    Bays, Derek
    Taylor, Sandra L.
    Cohen, Stuart H.
    Pappagianis, Demosthenes
    MEDICAL MYCOLOGY, 2013, 51 (03) : 319 - 323
  • [39] Serum 25-hydroxyvitamin D level in type 2 diabetes mellitus: Association with microvascular complications and type of treatment
    Suzuki, A
    Kotake, M
    Ono, Y
    Nishiwaki-Yasuda, K
    Matsumoto, T
    Imamura, S
    Kato, T
    Nagata, M
    Hayakawa, N
    Oda, N
    Itoh, M
    BONE, 2005, 36 : S459 - S459
  • [40] Association of 25-hydroxyvitamin D with cardiometabolic risk factors and metabolic syndrome: a mendelian randomization study
    Chen, Chi
    Chen, Yi
    Weng, Pan
    Xia, Fangzhen
    Li, Qin
    Zhai, Hualing
    Wang, Ningjian
    Lu, Yingli
    NUTRITION JOURNAL, 2019, 18 (01)